Target type: biologicalprocess
The transcription of a small interfering RNA from an RNA template. [PMID:23001036]
siRNA transcription is the process by which small interfering RNA (siRNA) molecules are produced from double-stranded RNA (dsRNA) precursors. This process is crucial for RNA interference (RNAi), a powerful gene silencing mechanism found in eukaryotes. Here is a detailed description of siRNA transcription:
1. **dsRNA Precursor Synthesis:** The process begins with the generation of a dsRNA precursor molecule. This can occur through various mechanisms, including:
* **Viral infection:** Some viruses, such as RNA viruses, produce dsRNA during their replication cycle.
* **Transfection:** dsRNA can be artificially introduced into cells through transfection methods.
* **Endogenous production:** Some cells can produce dsRNA through endogenous pathways, such as the processing of hairpin-structured RNAs.
2. **Dicer Processing:** The dsRNA precursor is then recognized and processed by a protein complex called Dicer. Dicer is a ribonuclease enzyme that cleaves the dsRNA into short, approximately 21-nucleotide-long fragments. These fragments are known as short interfering RNAs (siRNAs).
* **Dicer specificity:** Dicer preferentially cleaves dsRNA with a 3' overhang of 2 nucleotides.
* **Dicer activity:** Dicer produces siRNAs with a 5' phosphate and a 3' hydroxyl group.
3. **siRNA Duplex Formation:** The siRNA fragments produced by Dicer are double-stranded molecules. Each siRNA molecule consists of a sense strand and an antisense strand.
* **Sense strand:** The sense strand of the siRNA has the same sequence as the target mRNA.
* **Antisense strand:** The antisense strand of the siRNA is complementary to the target mRNA.
4. **RISC Assembly:** The siRNA duplex associates with the RNA-induced silencing complex (RISC). RISC is a multi-protein complex that plays a central role in RNAi.
* **RISC components:** RISC includes proteins such as Argonaute (Ago), which possesses endonuclease activity.
* **Strand selection:** Within RISC, the antisense strand of the siRNA is preferentially selected and incorporated into the active RISC complex.
5. **Target mRNA Recognition and Cleavage:** The antisense strand of the siRNA within RISC guides the complex to the target mRNA. The antisense strand binds to the complementary sequence within the mRNA through base pairing.
* **Target specificity:** The precise sequence complementarity between the antisense strand and the target mRNA ensures high specificity of RNAi.
* **Cleavage:** Once bound to the target mRNA, the Ago protein within RISC cleaves the mRNA molecule, leading to its degradation.
6. **Gene Silencing:** The degradation of the target mRNA prevents the translation of the corresponding gene into a protein. This results in a reduction or complete silencing of gene expression.
In summary, siRNA transcription involves the production of short interfering RNAs (siRNAs) from dsRNA precursors. These siRNAs guide the RNA-induced silencing complex (RISC) to target mRNAs, leading to their cleavage and subsequent gene silencing. The process of siRNA transcription is a vital component of RNA interference, a powerful mechanism that plays a crucial role in regulating gene expression in eukaryotic cells.'
"
Protein | Definition | Taxonomy |
---|---|---|
Telomerase reverse transcriptase | A telomerase reverse transcriptase that is encoded in the genome of human. [PRO:DNx, UniProtKB:O14746] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
7,8-dihydroxyflavone | 7,8-dihydroxyflavone : A dihydroxyflavone that is flavone substituted by hydroxy groups at positions 7 and 8. A dihydroxyflavone that is flavone substituted by hydroxy groups at positions 7 and 8. A naturally occurring flavonoid produced by several plants, including the weed Tridax procumbens (coalbuttons or tridax daisy) and the tree Godmania aesculifolia, In animal models, it has shown efficacy against several diseases of the nervous system, including Alzheimer's, Parkinson's, and Huntington's. | dihydroxyflavone | antidepressant; antineoplastic agent; antioxidant; plant metabolite; tropomyosin-related kinase B receptor agonist |
ethacridine | Ethacridine: A topically applied anti-infective agent. | acridines | |
berberine | alkaloid antibiotic; berberine alkaloid; botanical anti-fungal agent; organic heteropentacyclic compound | antilipemic drug; antineoplastic agent; antioxidant; EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor; EC 1.21.3.3 (reticuline oxidase) inhibitor; EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.11.10 (IkappaB kinase) inhibitor; EC 3.1.1.4 (phospholipase A2) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; hypoglycemic agent; metabolite; potassium channel blocker | |
9,10-phenanthrenequinone | 9,10-phenanthrenequinone: structure | phenanthrenes | |
ethidium bromide | organic bromide salt | geroprotector; intercalator; trypanocidal drug | |
camptothecin | NSC 100880: carboxylate (opened lactone) form of camptothecin; RN refers to (S)-isomer; structure given in first source | delta-lactone; pyranoindolizinoquinoline; quinoline alkaloid; tertiary alcohol | antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; genotoxin; plant metabolite |
staurosporine | indolocarbazole alkaloid; organic heterooctacyclic compound | apoptosis inducer; bacterial metabolite; EC 2.7.11.13 (protein kinase C) inhibitor; geroprotector | |
acridine orange | acridine orange : Fluorescent dye useful for cell cycle determination. It is cell-permeable, and interacts with DNA and RNA by intercalation or electrostatic attractions respectively. acridine orange free base : A member of the class of aminoacridines that is acridine carrying two dimethylamino substituents at positions 3 and 6. The hydrochloride salt is the fluorescent dye 'acridine orange', used for cell cycle determination. Acridine Orange: A cationic cytochemical stain specific for cell nuclei, especially DNA. It is used as a supravital stain and in fluorescence cytochemistry. It may cause mutations in microorganisms. | aminoacridines; aromatic amine; tertiary amino compound | fluorochrome; histological dye |
epigallocatechin gallate | (-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis) | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
meridine | meridine: polycyclic alkaloid derived from the marine sponge Corticium sp; structure given in first source | ||
cryptolepine | cryptolepine : An organic heterotetracyclic compound that is 5H-indolo[3,2-b]quinoline in which the hydrogen at position N-5 is replaced by a methyl group. cryptolepine: fused indole-quinoline; structure in first source; from CRYPTOLEPIS sanguinolenta | indole alkaloid; organic heterotetracyclic compound; organonitrogen heterocyclic compound | anti-inflammatory agent; antimalarial; antineoplastic agent; cysteine protease inhibitor; plant metabolite |
quindoline | quindoline: a fused indole-quinoline alkaloid from CRYPTOLEPIS sanguinolenta; structure | ||
u 73122 | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione: structure given in first source U-73122 : An aza-steroid that is 3-O-methyl-17beta-estradiol in which the 17beta-hydroxy group is replaced by a 6-(maleimid-1-yl)hexylamino group. An inibitor of phospholipase C. | aromatic ether; aza-steroid; maleimides | EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor |
celastrol | monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite | |
alteichin | alteichin: unusual phytotoxin from Alternaria eichorniae, fungal pathogen of water hyacinth; doubly hydrated form of 4,9-dihydroxyperylene-3,10-quinone | polyphenol | |
3',4'-dihydroxyflavone | 3',4'-dihydroxyflavone: inhibitors of arachidonic acid peroxidation | ||
tanshinone ii a | tashinone IIA: a cardiovascular agent with antineoplastic activity; isolated from Salvia miltiorrhiza; structure in first source | abietane diterpenoid | |
Telomestatin | 1,3-oxazoles | ||
7,8,3'-trihydroxyflavone | 7,8,3'-trihydroxyflavone: a potent small molecule TrkB receptor agonist that protects spiral ganglion neurons from degeneration both in vitro and in vivo | ||
2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-one | flavones | ||
7,8,4'-trihydroxyflavone | |||
okanin | okanin : A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 3, 4, 2', 3', and 4' respectively. okanin: hypoglycemic from Coreopsis tinctoria; structure in first source | benzenetriol; chalcones | plant metabolite |
3',4',7-trihydroxyflavone | 3',4',7-trihydroxyflavone: from the Sudanese medicinal plant Albizia zygia; structure in first source | flavones | |
beta-rubromycin | beta-rubromycin: structure given in first source | ||
mkt 077 | MKT 077: structure given in first source | ||
braco-19 | BRACO-19: structure in first source | acridines; N-alkylpyrrolidine | |
bibr 1532 | |||
n'-(10h-indolo(3,2-b)quinolin-11-yl)-n,n-dimethylpropane-1,3-diamine |